110 results on '"Jamshidi, Hamid Reza"'
Search Results
2. The protection quest is a primary key to sharing the neutralizing antibody response to cover against all emerging VOCs based on BIV1-CovIran studies
- Author
-
Shafaati, Maryam, Bagherzadeh, Kowsar, Lotfinia, Majid, Karimi, Hesam, Teimoori, Ali, Razazian, Mehdi, Meidaninikjeh, Sepideh, Hosseini, Hamed, Jamshidi, Hamid Reza, Jalili, Hasan, and Abdoli, Asghar
- Published
- 2023
- Full Text
- View/download PDF
3. Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019
- Author
-
Farzadfar, Farshad, Naghavi, Mohsen, Sepanlou, Sadaf G, Saeedi Moghaddam, Sahar, Dangel, William James, Davis Weaver, Nicole, Aminorroaya, Arya, Azadnajafabad, Sina, Koolaji, Sogol, Mohammadi, Esmaeil, Rezaei, Negar, Abbas, Jaffar, Abbasi, Behzad, Abbasifard, Mitra, Abbasi-Kangevari, Mohsen, Abbasi-Kangevari, Zeinab, Abbastabar, Hedayat, Abdoli, Amir, Abdollahi, Mohammad, Abdollahzade, Sina, Abolhassani, Hassan, Abrehdari-Tafreshi, Zahra, Aghababaei, Soodabeh, Ahadinezhad, Bahman, Ahmadi, Ali, Ahmadi, Sepideh, Ahmadieh, Hamid, Akbari, Mohammad Esmaeil, Alimohamadi, Yousef, Alipour, Vahid, Alizade, Hesam, Alvand, Saba, Amini, Saeed, Amiri, Sohrab, Anoushirvani, Ali Arash, Ansari, Fereshteh, Arabloo, Jalal, Arab-Zozani, Morteza, Aryan, Zahra, Aryannejad, Armin, Asadi-Aliabadi, Mehran, Asadi-Pooya, Ali A, Asemi, Zatollah, Asgari, Samaneh, Asgary, Saeed, Asghari, Babak, Asghari Jafarabadi, Mohammad, Ashrafi, Elham, Atafar, Zahra, Athari, Seyyed Shamsadin, Avan, Abolfazl, Azadmehr, Abbas, Azami, Hiva, Azangou-Khyavy, Mohammadreza, Azari, Samad, Azari Jafari, Amirhossein, Azarian, Ghasem, Badirzadeh, Alireza, Bahrami, Elham, Bahrami, Mohammad Amin, Barati, Nastaran, Bayati, Mohsen, Bazmandegan, Gholamreza, Behzadifar, Masoud, Bijani, Ali, Bohlouli, Somayeh, Borzouei, Shiva, Daneshpajouhnejad, Parnaz, Dargahi, Abdollah, Daryani, Ahmad, Davoodi Lahijan, Jalal, Didehdar, Mojtaba, Djalalinia, Shirin, Doaei, Saeid, Dorostkar, Fariba, Doshmangir, Leila, Edraki, Mohammadreza, Emami, Amir, Eshrati, Babak, Eskandarieh, Sharareh, Esmaeilzadeh, Firooz, Faghani, Shahriar, Fakhar, Mahdi, Farpour, Hamid Reza, Farrokhpour, Hossein, Fasihi Harandi, Majid, Fereidouni, Mohammad, Foroutan, Masoud, Ghafourifard, Mansour, Ghamari, Azin, Ghamari, Seyyed-Hadi, Ghashghaee, Ahmad, Ghassemi, Fariba, Gholami, Ali, Gholamian, Asadollah, Gholizadeh, Abdolmajid, Goharinezhad, Salime, Goleij, Pouya, Hadei, Mostafa, Hafezi-Nejad, Nima, Hariri, Sanam, Hasanpoor, Edris, Hassanian-Moghaddam, Hossein, Hassanipour, Soheil, Hassankhani, Hadi, Heidari, Mohammad, Heidari-Soureshjani, Reza, Hoseini, Mohammad, Hosseini, Mohammad-Salar, Hosseini, Mostafa, Hosseini, Seyed Kianoosh, Hosseinzadeh, Ali, Hosseinzadeh, Mehdi, Hoveidamanesh, Soodabeh, Iranpour, Pooya, Irvani, Seyed Sina Naghibi, Jaafari, Jalil, Jabbarinejad, Roxana, Jafarinia, Morteza, Jafari-Vayghan, Hamed, Jahani, Mohammad Ali, Jahanmehr, Nader, Jalili, Mahsa, Janghorban, Roksana, Javanmardi, Fatemeh, Joukar, Farahnaz, Kabir, Ali, Kalankesh, Leila R, Kalhor, Rohollah, Kamiab, Zahra, Kamyari, Naser, Karami Matin, Behzad, Karimi, Amirali, Karimi, Salah Eddin, Kazemi Karyani, Ali, Keikavoosi-Arani, Leila, Keramati, Maryam, Keshavarz, Pedram, Keykhaei, Mohammad, Khaleghi, Ali, Khammarnia, Mohammad, Khanali, Javad, Khayamzadeh, Maryam, Khosravi, Sajad, Khosravifar, Mina, Khosravizadeh, Omid, Kianipour, Neda, Kolahi, Ali-Asghar, Maali, Amirhosein, Mahdavi, Mokhtar Mahdavi, Maleki, Afshin, Malekpour, Mohammad-Reza, Mansori, Kamyar, Mansouri, Borhan, Mansournia, Mohammad Ali, Maracy, Mohammad Reza, Marjani, Abdoljalal, Masoudi, Sahar, Masoumi, Seyedeh Zahra, Masoumi-Asl, Hossein, Mayeli, Mahsa, Mehrabi Nasab, Entezar, Mehri, Fereshteh, Miri, Mohammad, Mirmoeeni, Seyyedmohammadsadeq, Mirzaei, Hamed, Mirzaei, Maryam, Mirzaei, Roya, Mohamadkhani, Ashraf, Mohammadi, Heidar, Mohammadi, Seyyede Momeneh, Mohammadi, Shadieh, Mohammadian-Hafshejani, Abdollah, Mohammadifard, Noushin, Mohammadpourhodki, Reza, Mohseni, Mohammad, Mokari, Amin, Momtazmanesh, Sara, Moradi, Abdolvahab, Moradi, Masoud, Moradi, Yousef, Moradi-Joo, Mohammad, Moradpour, Farhad, Moradzadeh, Maliheh, Moradzadeh, Rahmatollah, Mosapour, Abbas, Moslehi, Shandiz, Mouodi, Simin, Naderi, Mehdi, Naderifar, Homa, Najafpour, Zhila, Nazari, Javad, Nejadghaderi, Seyed Aria, Nemati-Anaraki, Leila, Nikpoor, Amin Reza, Nojomi, Marzieh, Noori, Maryam, Nouraei, Hasti, Nowroozi, Ali, Oladnabi, Morteza, Pashazadeh Kan, Fatemeh, Pirestani, Majid, Pirsaheb, Meghdad, Pourahmadi, Mohammadreza, Pourchamani, Hadis, Pourjafar, Hadi, Pourshams, Akram, Rabiee, Mohammad, Rabiee, Navid, Rafiei, Alireza, Rafiei, Sima, Rahim, Fakher, Rahmani, Amir Masoud, Rashedi, Sina, Rashedi, Vahid, Rashidi, Amirfarzan, Rashidi, Mahsa, Rashidi, Mohammad-Mahdi, Ravangard, Ramin, Rawassizadeh, Reza, Razeghian-Jahromi, Iman, Razeghinia, Mohammad Sadegh, Redford, Sofia B, Rezaei, Maryam, Rezaei, Nazila, Rezaei, Nima, Rezaei, Saeid, Rezaei Aliabadi, Hossein, Rezaeian, Mohsen, Rezai, Mohammad Sadegh, Rezapour, Aziz, Rezazadeh, Hossein, Rezazadeh-Khadem, Sahba, Rostamian, Morteza, Sadeghi, Ehsan, Sadeghi, Erfan, Sadeghi, Masoumeh, Sadeghian, Reihaneh, Sadeghian, Saeid, Safarpour, Hamid, Safdarian, Mahdi, Safi, Sare, Sahebazzamani, Maryam, Sahebkar, Amirhossein, Sahraian, Mohammad Ali, Salahi, Sarvenaz, Salamati, Payman, Samadi Kafil, Hossein, Sarikhani, Yaser, Sarkhosh, Maryam, Sarveazad, Arash, Seyed-Nezhad, Maryam, Shafaat, Omid, Shaghaghi, Zahra, Shahabi, Saeed, Shahin, Sarvenaz, Shaker, Elaheh, Shakiba, Saeed, Shamsi, MohammadBagher, Shamsoddin, Erfan, Sharafi, Kiomars, Sharifian, Sakineh, Shaygan, Maryam, Sheikhtaheri, Abbas, Shiani, Amir, Shirbandi, Kiarash, Shirkoohi, Reza, Shobeiri, Parnian, Shokri, Azad, Siabani, Soraya, Sima, Ali Reza, Sofi-Mahmudi, Ahmad, Soheili, Amin, Soltani, Shahin, Soltani-Zangbar, Mohammad Sadegh, Soofi, Moslem, Tabaeian, Seidamir Pasha, Tabary, Mohammadreza, Tahamtan, Alireza, Taheri, Majid, Taherkhani, Amir, Tajdini, Masih, Tavolinejad, Hamed, Tehrani-Banihashemi, Arash, Tiyuri, Amir, Tohidast, Seyed Abolfazl, Vakilian, Alireza, Valadan Tahbaz, Sahel, Vo, Bay, Yahyazadeh Jabbari, Seyed Hossein, Yazdi-Feyzabadi, Vahid, Yousefi, Zabihollah, Yousefinezhadi, Taraneh, Zahir, Mazyar, Zahirian Moghadam, Telma, Zamanian, Maryam, Zandian, Hamed, Zangeneh, Alireza, Zarafshan, Hadi, Zare, Fariba, Zare Dehnavi, Ali, Zarea, Kourosh, Zarei, Ahmad, Zareshahrabadi, Zahra, Ziapour, Arash, Zoghi, Sina, Sarrafzadegan, Nizal, Rahimi-Movaghar, Vafa, Jamshidi, Hamid Reza, Mokdad, Ali H, Hay, Simon I, Murray, Christopher J L, Khosravi, Ardeshir, Moradi-Lakeh, Maziar, Asadi-Lari, Mohsen, Malekzadeh, Reza, and Larijani, Bagher
- Published
- 2022
- Full Text
- View/download PDF
4. Evaluation of Changes in Acetylcholinesterase Activity in Workers of Mehriz Elixir Pesticide Plant in Yazd
- Author
-
Jamshidi, Hamid Reza, primary and Bakhtiari, Leila, additional
- Published
- 2024
- Full Text
- View/download PDF
5. Development and Assessment of a Mucoadhesive Formulation Incorporating Phenytoin for Wound Healing
- Author
-
Mehrjardi, Soheil Tafazzoli, primary, Jamshidi, Hamid Reza, additional, and Ramezani, Vahid, additional
- Published
- 2024
- Full Text
- View/download PDF
6. Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern
- Author
-
Salehi, Mohammadreza, Hosseini, Hamed, Jamshidi, Hamid Reza, Jalili, Hasan, Tabarsi, Payam, Mohraz, Minoo, Karimi, Hesam, Lotfinia, Majid, Aalizadeh, Reza, Mohammadi, Mehrdad, Ramazi, Shahin, and Abdoli, Asghar
- Published
- 2022
- Full Text
- View/download PDF
7. Birth seasonality in rural areas of Iran, analysis of 5,536,262 births from 1992 to 2007
- Author
-
Khajavi, Alireza, Pishgar, Farhad, Parsaeian, Mahboubeh, Moghaddam, Sahar Saeedi, Jeddian, Alireza, Bahrami-Taghanaki, Hamid Reza, Jamshidi, Hamid Reza, and Naderimagham, Shohreh
- Published
- 2016
- Full Text
- View/download PDF
8. Clinical Trial of Intraperitoneal Administration of Ketamine Combined with Bupivacaine on Pain Status after Laparoscopic Cholecystectomy
- Author
-
Ziaei, Parvin, primary, Kargar, Saeed, additional, Dehghan, Mohammad Hossein, additional, Madadizadeh, Farzan, additional, and Jamshidi, Hamid Reza, additional
- Published
- 2023
- Full Text
- View/download PDF
9. Optimization of Ventilation Therapy Prioritization Strategies among Patients with COVID-19: Lessons Learned from Real-World Data of nearly 600,000 Hospitalized Patients
- Author
-
Abbasi-Kangevari, Mohsen, primary, Ghanbari, Ali, additional, Malekpour, Mohammad-Reza, additional, Ghamari, Seyyed-Hadi, additional, Azadnajafabad, Sina, additional, Moghaddam, Sahar Saeedi, additional, Keykhaei, Mohammad, additional, Haghshenas, Rosa, additional, Golestani, Ali, additional, Rashidi, Mohammad-Mahdi, additional, Rezaei, Nazila, additional, Ghasemi, Erfan, additional, Rezaei, Negar, additional, Jamshidi, Hamid Reza, additional, and Larijani, Bagher, additional
- Published
- 2022
- Full Text
- View/download PDF
10. Combining government, non-pharmaceutical interventions and vaccination in optimal control COVID-19
- Author
-
Bohloli, Hamid, primary, Jamshidi, Hamid Reza, additional, Ebraze, Ali, additional, and Rabbani Khah, Fahimeh, additional
- Published
- 2022
- Full Text
- View/download PDF
11. Combining government, non-pharmaceutical interventions and vaccination in optimal control COVID-19.
- Author
-
Bohloli, Hamid, Jamshidi, Hamid Reza, Ebraze, Ali, and Rabbani Khah, Fahimeh
- Subjects
SCIENTIFIC literature ,COMMUNICABLE diseases ,COVID-19 pandemic ,COVID-19 ,TRAFFIC regulations ,SOAP - Abstract
This study reviews the scope of scientific literature to convey extensive multi-factor studies for recognizing various government and behavioral interventions in controlling the COVID-19 globally to determine the extent and nature of these interventions. We provide a novel theory and formula for contingency action based on the COVID-19 Sine Wave points to control the pandemic. Rather than telling policy-makers what to do, the theory tells them what to do at any given time. It emphasizes the importance of time in managing a contagious disease like COVID-19, which is the novelty and difference between this article and others. In this regard, the novel Sine Wave Contingency-Point Interventions (SWCPI) Model is presented. We propose a model that predicts the path of epidemics and evaluates the impact of various strategies to curb the spread of infection. This model includes government interventions [(GI: quarantine, large traffic restrictions, Law enforcement, (LES: logistic, economic and security supports)] and Non-Pharmaceutical Interventions (NPIs: washing hands, use of face mask, social distancing, local traffic restriction, and suitable air condition) and urban health interventions (4T: Timing, Testing, Tracing and Treatment). If these contingency interventions are implemented seriously and regularly, it could control the COVID-19 and flatten the subsequent waves. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. The Effect of Thymol on Renal Toxicity Induced by Mercury Chloride in Rats
- Author
-
Jamshidi, Hamid Reza, primary and Taheri, Faezeh, additional
- Published
- 2021
- Full Text
- View/download PDF
13. Effect of Thymol on the Level of Bcl-2 Family Transcript in the Hypertrophied Heart of Rats
- Author
-
Safari, Fatemeh, primary, Atarodi, Reza, additional, and Jamshidi, Hamid Reza, additional
- Published
- 2021
- Full Text
- View/download PDF
14. Effects of Thymol on Co-amoxiclav-Induced Hepatotoxicity in Rats
- Author
-
Jamshidi, Hamid Reza, primary and Negintaji, Sina, additional
- Published
- 2021
- Full Text
- View/download PDF
15. Socioeconomic inequality in infant mortality in Iran and across its provinces
- Author
-
Hosseinpoor, Ahmad Reza, Mohammad, Kazem, Majdzadeh, Reza, Naghavi, Mohsen, Abolhassani, Farid, Sousa, Angelica, Speybroeck, Niko, Jamshidi, Hamid Reza, and Vega, Jeanette
- Subjects
World Health Organization -- Reports ,Infants -- Health aspects ,Mortality -- Reports ,Mortality -- Iran - Abstract
Objective To measure the socioeconomic inequality in infant mortality in Iran *. Methods We analysed data from the provincially representative Demographic and Health Survey, which was done in Iran in 2000. We used a dichotomous hierarchical ordered probit model to develop an indicator of socioeconomic status of households. We assessed the inequality in infant mortality by using the odds ratio of infant mortality between the lowest and highest socioeconomic quintiles at both the provincial and national levels, and the concentration index, an inequality measure based on the entire socioeconomic distribution, Results We found a decreasing trend in the infant mortality rate in relation to socioeconomic quintiles. The poorest to richest odds ratio was 2.34 (95% CI = 1.78-3.09). The concentration index of infant mortality in Iran was -0.1789 (95% CI = -0.2193-0.1386). Furthermore, the inequality of infant mortality between the lowest and highest quintiles was significant and favoured the better-off in most of the provinces. However, this inequality varied between provinces. Conclusion Socioeconomic inequality in infant mortality favours the better-off in the country as a whole and in most of its provinces, but the degree of this inequality varies between the provinces. As well as its national average, it is important to consider the provincial distribution of this indicator of population health. Keywords Infant mortality; Socioeconomic factors; Economic indicators; Odds ratio; Iran (Islamic Republic of) (source: MESH, NLM). Mots cles Mortalite nourrisson; Facteur socioeonomique; Indicateurs economiques; Odds ratio; Iran (Republique islamique d') (source: MESH, INSERM). Palabras clave Mortalidad infantil; Factores socioeconomicos: Indicadores economicos; Razon de diferencia; Iran (Republica Islamica del) (fuente: DeCS, BIREME). Bulletin of the World Health Organization 2005;83:837-844. Voir page 843 le resume en francais. En la pagina 843 figura un resumen en espanol., Introduction More than 10 million children die each year in the world (1). That is why child mortality has received renewed attention as part of the United Nation's Millennium Development [...]
- Published
- 2005
16. Protective Effect of Mito-TEMPO on Sodium Valproate-Induced Hepatotoxicity in Mice
- Author
-
Jamshidi, Hamid Reza, primary, Emami, Azadeh, additional, Golmohammadi, Hossein, additional, and Tavakoli, Fatemeh, additional
- Published
- 2020
- Full Text
- View/download PDF
17. Effect of Sodium Selenide on Renal Toxicity Induced By Mercuric Chloride in Rat
- Author
-
Jamshidi, Hamid Reza, primary and Kalantar, Hasti, additional
- Published
- 2020
- Full Text
- View/download PDF
18. Evolution and Comparison Effects of Fludrocortisone and Betamethasone on Glucose and Lipid Profile in Rats
- Author
-
Jamshidi, Hamid Reza, primary and Naeem Malmir, Mohammad, additional
- Published
- 2020
- Full Text
- View/download PDF
19. Iran in transition
- Author
-
Danaei, Goodarz, Farzadfar, Farshad, Kelishadi, Roya, Rashidian, Arash, Rouhani, Omid M., Ahmadnia, Shirin, Ahmadvand, Alireza, Arabi, Mandana, Ardalan, Ali, Arhami, Mohammad, Azizi, Mohammad Hossein, Bahadori, Moslem, Baumgartner, Jill, Beheshtian, Arash, Djalalinia, Shirin, Doshmangir, Leila, Haghdoost, Ali Akbar, Haghshenas, Rosa, Hosseinpoor, Ahmad Reza, Islami, Farhad, Kamangar, Farin, Khalili, Davood, Madani, Kaveh, Masoumi-Asl, Hossein, Mazyaki, Ali, Mirchi, Ali, Moradi, Ehsan, Nayernouri, Touraj, Niemeier, Debbie, Omidvari, Amir-Houshang, Peykari, Niloofar, Pishgar, Farhad, Qorbani, Mostafa, Rahimi, Kazem, Rahimi-Movaghar, Afarin, Tehrani, Fahimeh Ramezani, Rezaei, Nazila, Shahraz, Saeid, Takian, Amirhossein, Tootee, Ali, Ezzati, Majid, Jamshidi, Hamid Reza, Larijani, Bagher, Majdzadeh, Reza, Malekzadeh, Reza, Danaei, Goodarz, Farzadfar, Farshad, Kelishadi, Roya, Rashidian, Arash, Rouhani, Omid M., Ahmadnia, Shirin, Ahmadvand, Alireza, Arabi, Mandana, Ardalan, Ali, Arhami, Mohammad, Azizi, Mohammad Hossein, Bahadori, Moslem, Baumgartner, Jill, Beheshtian, Arash, Djalalinia, Shirin, Doshmangir, Leila, Haghdoost, Ali Akbar, Haghshenas, Rosa, Hosseinpoor, Ahmad Reza, Islami, Farhad, Kamangar, Farin, Khalili, Davood, Madani, Kaveh, Masoumi-Asl, Hossein, Mazyaki, Ali, Mirchi, Ali, Moradi, Ehsan, Nayernouri, Touraj, Niemeier, Debbie, Omidvari, Amir-Houshang, Peykari, Niloofar, Pishgar, Farhad, Qorbani, Mostafa, Rahimi, Kazem, Rahimi-Movaghar, Afarin, Tehrani, Fahimeh Ramezani, Rezaei, Nazila, Shahraz, Saeid, Takian, Amirhossein, Tootee, Ali, Ezzati, Majid, Jamshidi, Hamid Reza, Larijani, Bagher, Majdzadeh, Reza, and Malekzadeh, Reza
- Abstract
Being the second-largest country in the Middle East, Iran has a long history of civilisation during which several dynasties have been overthrown and established and health-related structures have been reorganised. Iran has had the replacement of traditional practices with modern medical treatments, emergence of multiple pioneer scientists and physicians with great contributions to the advancement of science, environmental and ecological changes in addition to large-scale natural disasters, epidemics of multiple communicable diseases, and the shift towards non-communicable diseases in recent decades. Given the lessons learnt from political instabilities in the past centuries and the approaches undertaken to overcome health challenges at the time, Iran has emerged as it is today. Iran is now a country with a population exceeding 80 million, mainly inhabiting urban regions, and has an increasing burden of non-communicable diseases, including cardiovascular diseases, hypertension, diabetes, malignancies, mental disorders, substance abuse, and road injuries.
- Published
- 2019
- Full Text
- View/download PDF
20. Evaluation of Glutamate Dehydrogenase Activity and Insulin Secretion in Mice Exposed to Dexamethasone
- Author
-
Jamshidi, Hamid Reza, primary and Ebrahimi, Elham, additional
- Published
- 2019
- Full Text
- View/download PDF
21. Effects of Parathion Toxin on Glutamate Dehydrogenase Enzyme Activity and Diabetes Induction
- Author
-
Jamshidi, Hamid Reza, primary and Ebrahimi, Elham, additional
- Published
- 2019
- Full Text
- View/download PDF
22. Iran in transition
- Author
-
Danaei, Goodarz, primary, Farzadfar, Farshad, additional, Kelishadi, Roya, additional, Rashidian, Arash, additional, Rouhani, Omid M, additional, Ahmadnia, Shirin, additional, Ahmadvand, Alireza, additional, Arabi, Mandana, additional, Ardalan, Ali, additional, Arhami, Mohammad, additional, Azizi, Mohammad Hossein, additional, Bahadori, Moslem, additional, Baumgartner, Jill, additional, Beheshtian, Arash, additional, Djalalinia, Shirin, additional, Doshmangir, Leila, additional, Haghdoost, Ali Akbar, additional, Haghshenas, Rosa, additional, Hosseinpoor, Ahmad Reza, additional, Islami, Farhad, additional, Kamangar, Farin, additional, Khalili, Davood, additional, Madani, Kaveh, additional, Masoumi-Asl, Hossein, additional, Mazyaki, Ali, additional, Mirchi, Ali, additional, Moradi, Ehsan, additional, Nayernouri, Touraj, additional, Niemeier, Debbie, additional, Omidvari, Amir-Houshang, additional, Peykari, Niloofar, additional, Pishgar, Farhad, additional, Qorbani, Mostafa, additional, Rahimi, Kazem, additional, Rahimi-Movaghar, Afarin, additional, Tehrani, Fahimeh Ramezani, additional, Rezaei, Nazila, additional, Shahraz, Saeid, additional, Takian, Amirhossein, additional, Tootee, Ali, additional, Ezzati, Majid, additional, Jamshidi, Hamid Reza, additional, Larijani, Bagher, additional, Majdzadeh, Reza, additional, and Malekzadeh, Reza, additional
- Published
- 2019
- Full Text
- View/download PDF
23. Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran
- Author
-
Khatibi, Mohsen, Rasekh, Hamid Reza, Shahverdi, Zohreh, and jamshidi, Hamid Reza
- Subjects
population characteristics ,Original Article ,Cost-Effectiveness ,Iran ,HPV vaccine - Abstract
Human Papilloma Virus (HPV) vaccine has been added recently to the Iran Drug List. So, decision makers need information beyond that available from RCTs to recommend funding for this vaccination program to add it to the National Immunization program in Iran. Modeling and economic studies have addressed some of those information needs in foreign countries. In order to determine the long term benefit of this vaccine and impact of vaccine program on the future rate of cervical cancer in Iran, we described a model, based on the available economic and health effects of human papilloma virus (HPV), to estimate the cost-effectiveness of HPV vaccination of 15-year-old girls in Iran. Our objective is to estimate the cost-effectiveness of HPV vaccination in Iran against cervical cancer based on available data; incremental cost-effectiveness ratio (ICER) calculations were based on a model comparing a cohort of 15-year-old girls with and without vaccination. We developed a static model based on available data in Iran on the epidemiology of HPV related health outcome. The model compared the cohort of all 15-year old girls alive in the year 2013 with and without vaccination. The cost per QALY, which was found based on our assumption for the vaccination of 15-years old girl to current situation was 439,000,000 Iranian Rial rate (IRR). By considering the key parameters in our sensitivity analysis, value varied from 251,000,000 IRR to 842,000,000 IRR. In conclusion, quadrivalent HPV vaccine (Gardasil) is not cost-effective in Iran based on the base-case parameters value.
- Published
- 2014
24. Risk assessment of particulate matters in a dentistry school using fuzzy inference systems
- Author
-
Jamshidi, Hamid Reza, primary, Karimi, Ali, additional, and Haghshenas, Mahin, additional
- Published
- 2018
- Full Text
- View/download PDF
25. Effects of parathion on the activity of mitochondrial glutamate dehydrogenase from rat pancreatic Langerhans islets
- Author
-
Jamshidi, Hamid Reza, primary, Ebrahimi, Elham, additional, and Moradi, Ali, additional
- Published
- 2017
- Full Text
- View/download PDF
26. Evolution and Comparison Effects of Fludrocortisone and Betamethasone on Glucose and Lipid Profile in Rats.
- Author
-
Jamshidi, Hamid Reza and Malmir, Mohammad Naeem
- Subjects
- *
GLUCOSE , *BLOOD sugar , *LIPIDS , *RATS , *INTRAPERITONEAL injections , *BETAMETHASONE - Abstract
Hyperglycemia may associate with improper use of glucocorticoids, impaired insulin function, or both, and is associated with many complications such as hyperlipidemia and Hyperglycemia. Researches suggest that proper use of glucocorticoids can delay the onset and progression of complications of hyperglycemia and hyperlipidemia. In the present study, we compare two of these compounds on glucose and lipid profile level. We use 40 male Wistar rats from the Yazd Animal infertility center. Initially, the rats were randomly divided into 2 groups, and then each group was divided into 4 groups. Subsequently, fludrocortisone doses of 12, 24 and 36 mg/kg were administered to rats, and dosages of 6, 12 and 18 mg/kg for betamethasone administered to rats on a daily basis at 1 o'clock for 21 days by intraperitoneal injection. Betamethasone and Fludrocortisone increased blood glucose and AST, ALT, TG, LDL, VLDL, and decreased HDL, causing red pigmentation in the skin, and obesity and puffiness of the rats. In all of the measured factors, fludrocortisone changes were more than betamethasone. Fludrocortisone and betamethasone also had significant effects on weight, which was more pronounced with fludrocortisone. As the dose increased, the levels of AST, ALT, and cholesterol, TG, VLDL and LDL in the blood increased significantly and HDL levels decreased more in the blood, but fludrocortisone showed a stronger effect than betamethasone. Therefore, it can be expected that the use of Betamethasone would be logical due to fewer side effects than fludrocortisone. [ABSTRACT FROM AUTHOR]
- Published
- 2019
27. Using drug sales data to evaluate the epidemiology of cardio-metabolic risk factors and their inequality: an ecological study on atorvastatin and total cholesterol in Iran
- Author
-
Ahmadvand, Alireza, Farzadfar, Farshad, Jamshidi, Hamid Reza, Mohammadi, Naser, Holakouie Naieni, Kourosh, Ahmadvand, Alireza, Farzadfar, Farshad, Jamshidi, Hamid Reza, Mohammadi, Naser, and Holakouie Naieni, Kourosh
- Abstract
Background: Statins have been effective medications in lowering serum total cholesterol (TC) concentrations across populations over time. The aim of this study was to estimate national and provincial trends in atorvastatin sales in Iran, to systematically quantify its relationship with socio-economic indicators, and changes in TC level. Methods: In this retrospective ecological study, conducted in Iran, we examined trends in atorvastatin sales, the wealth index (WI) as a validly-available socio-economic indicator, and TC level between 2004 and 2011. The main outcome variable was mean atorvastatin sold in defined daily dose per 100,000 people per day (DPD). We analyzed the relationship between WI and DPD and between DPD and mean TC across time and space. Results: At national level, both mean WI and mean DPD showed increasing trend over time, while we observed decreasing trend for TC. Mean WI and DPD in 2011 was nearly 5 and 50 time that of their respective figures in 2004, while the mean TC decreased for nearly 10%. Increases in both WI and DPD had happened in every province, but with different patterns. The maximum and minimum changes in DPD versus WI were seen in Gilan and North Khorasan respectively. Conclusion: A striking increase occurred in the sales for atorvastatin in Iran from 2004-2012 in most provinces examined. The wealthier a province became, the more sales were seen for atorvastatin. TC optimistically decreased from 2005 to 2011 and its decrease was positively correlated with increasing sales for atorvastatin.
- Published
- 2015
28. National and sub-national prevalence, trend, and burden of metabolic risk factors (MRFs) in Iran: 1990-2013, study protocol
- Author
-
Peykari, Niloofar, Sepanlou, Sadaf, Djalalinia, Shirin, Kasaeian, Amir, Parsaeian, Mahboubeh, Ahmadvand, Alireza, Koohpayehzadeh, Jalil, Damari, Behzad, Jamshidi, Hamid Reza, Larijani, Bagher, Farzadfar, Farshad, Peykari, Niloofar, Sepanlou, Sadaf, Djalalinia, Shirin, Kasaeian, Amir, Parsaeian, Mahboubeh, Ahmadvand, Alireza, Koohpayehzadeh, Jalil, Damari, Behzad, Jamshidi, Hamid Reza, Larijani, Bagher, and Farzadfar, Farshad
- Abstract
BACKGROUND: Non-communicable diseases (NCDs) and their risk factors are the major public health problems. There are some documented trend and point estimations of metabolic risk factors for Iranian population but there are little information about their exposure distribution at sub-national level and no information about their trends and their effects on the population health. METHODS: The present study protocol is aimed to provide the standard structure definitions, organization, data sources, methods of data gathering or generating, and data on trend analysis of the metabolic risk factors in NASBOD study. We will estimate 1990 to 2013 trends of prevalence, years of life lost due to premature mortality (YLLs), and years lived with disability (YLDs) and disability-adjusted life years DALYs for MRFs by gender, age group, and province. We will also quantify the uncertainty interval for the estimates of interest. CONCLUSION: The findings of study could provide practical information regarding metabolic risk factors and their burden for better health policy to reduce the burden of diseases, and to plan cost-effective preventive strategies. The results also could be used for future complementary global, regional, national, and sub national studies.
- Published
- 2014
29. Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy
- Author
-
Foroutan,Naghmeh, Rasekh,Hamid Reza, Salamzadeh,Jamshid, Jamshidi,Hamid Reza, Nafar,Mohsen, Foroutan,Naghmeh, Rasekh,Hamid Reza, Salamzadeh,Jamshid, Jamshidi,Hamid Reza, and Nafar,Mohsen
- Abstract
Naghmeh Foroutan,1 Hamid R Rasekh,1 Jamshid Salamzadeh,1 Hamid R Jamshidi,1 Mohsen Nafar2 1Department of Pharmacoeconomics and Pharmaceutical Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, 2Department of Kidney Transplantation, Urinary Nephrology Research Center (UNRC), Shahid Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran Objectives: The aim of this study was to determine budget impact of conversion from cyclosporine (CsA) to sirolimus (SRL) in renal transplant therapy (RTT) from the perspective of insurance organizations in Iran. Methods: An Excel-based model was developed to determine cost of RTT, comparing current CsA based therapy to an mTOR inhibitor-based therapy regimen. Total cost included both cost of immunosuppressive agents and relative adverse events. The inputs were derived from database of Ministry of Health and insurance organizations, hospital and pharmacy based registries, and available literature that were varied through a one-way sensitivity analysis. According to the model, there were almost 17,000 patients receiving RTT in Iran, out of which about 2,200 patients underwent the operation within the study year. The model was constructed based on the results of a local RCT, in which test and control groups received CsA, SRL, and steroids over the first 3 months posttransplantation and, from the fourth month on, CsA, mycophenolate mofetil (MMF), and steroids were used in the CsA group and SRL, MMF, and steroids were administered in the SRL group, respectively. Results: The estimated cost of RTT with CsA was US$4,850,000 versus US$4,300,000 receiving SRL. These costs corresponded to the cost saving of almost US$550,000 for the payers. Conclusion: To evaluate the financial consequence of adding mTOR inhibitors to the insurers’ formulary, in the present study, a budget impact analysis was conducted on sirolimus. Fewer cases of costly adverse events along with lower re
- Published
- 2013
30. Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy
- Author
-
Foroutan, Naghmeh, primary, Rasekh, Hamid Reza, additional, Salamzadeh, Jamshid, additional, Jamshidi, Hamid Reza, additional, and Nafar, Mohsen, additional
- Published
- 2013
- Full Text
- View/download PDF
31. Socioeconomic inequality in infant mortality in Iran and across its provinces
- Author
-
WHO, Hosseinpoor, Ahmad Reza, Mohammad, Kazem, Majdzadeh, Reza, Naghavi, Mohsen, Abolhassani, Farid, Sousa, Angelica, Speybroeck, Niko, Jamshidi, Hamid Reza, Vega, Jeanette, WHO, Hosseinpoor, Ahmad Reza, Mohammad, Kazem, Majdzadeh, Reza, Naghavi, Mohsen, Abolhassani, Farid, Sousa, Angelica, Speybroeck, Niko, Jamshidi, Hamid Reza, and Vega, Jeanette
- Abstract
Objective To measure the socioeconomic inequality in infant mortality in Iran*. Methods We analysed data from the provincially representative Demographic and Health Survey, which was done in Iran in 2000. We used a dichotomous hierarchical ordered probit model to develop an indicator of socioeconomic status of households. We assessed the inequality in infant mortality by using the odds ratio of infant mortality between the lowest and highest socioeconomic quintiles at both the provincial and national levels, and the concentration index, an inequality measure based on the entire socioeconomic distribution. Results We found a decreasing trend in the infant mortality rate in relation to socioeconomic quintiles. The poorest to richest odds ratio was 2.34 (95% CI = 1.78–3.09). The concentration index of infant mortality in Iran was -0.1789 (95% CI =-0.2193–-0.1386). Furthermore, the inequality of infant mortality between the lowest and highest quintiles was significant and favoured the better-off in most of the provinces. However, this inequality varied between provinces. Conclusion Socioeconomic inequality in infant mortality favours the better-off in the country as a whole and in most of its provinces, but the degree of this inequality varies between the provinces. As well as its national average, it is important to consider the provincial distribution of this indicator of population health
- Published
- 2005
32. Effects of diazinon on the activity and gene expression of mitochondrial glutamate dehydrogenase from rat pancreatic Langerhans islets
- Author
-
Jamshidi, Hamid Reza, primary, Ghahremani, Mohammad Hossein, additional, Ostad, Seyed Nasser, additional, Sharifzadeh, Mohammad, additional, Dehpour, Ahmad Reza, additional, and Abdollahi, Mohammad, additional
- Published
- 2009
- Full Text
- View/download PDF
33. Prevention by L-Arginine/Nitric Oxide of Chlordiazepoxide-Induced Toxic Reactions in the Rat Salivary Gland
- Author
-
Ahmed, Abdollah Osman, primary, Sharifzadeh, Mohammad, additional, Nikfar, Shekoufeh, additional, Jamshidi, Hamid Reza, additional, and Abdollahi, Mohammad, additional
- Published
- 2006
- Full Text
- View/download PDF
34. "Budget Impact Analyses": A Practical Policy Making Tool for Drug Reimbursement Decisions.
- Author
-
Jamshidi, Hamid Reza, Foroutan, Naghmeh, and Salamzadeh, Jamshid
- Subjects
- *
DRUG development , *PHARMACEUTICAL chemistry , *DECISION making , *BUDGET , *FINANCE ,IRAN. Ministry of Health - Abstract
In the present article, Budget Impact Analysis as an effective, practical financial tool has been introduced to the policy makers for improving drug formulary and reimbursement decision making. In Iran, Ministry of Health (MOH), health insurance organizations, and health care providers such as hospitals could take the most advantage of the BIAs reports. [ABSTRACT FROM AUTHOR]
- Published
- 2014
35. The Effect of Ziziphus Jujuba Fruit Extract in Diabetic and Non-Diabetic Rat.
- Author
-
Jamshidi, Hamid Reza, Mosaddegh, Mohammad Hossein, Vahidi, Ali Reza, Ghasemian, Mona, and Mohammadi, Nahid Haj
- Subjects
- *
TREATMENT of diabetes , *JUJUBE (Plant) , *HERBAL medicine , *BLOOD sugar , *AMINOTRANSFERASES , *TRIGLYCERIDES , *PLANT extracts , *THERAPEUTICS - Abstract
Objective:Herbal medicine and medical plants such as Ziziphus Jujuba are widely used in the treatment of diseases such as diabetes mellitus. We investigated the effects of ethanol extracts of Ziziphus Jujuba fruit on serum glucose, triglycerides, LDL-cholesterol, HDL-cholesterol, cholesterol and activities of aminotransferase enzymes in streptozocin-induced diabetic adult male rats. Materials and Methods: Adult Wistar rats were rendered hyperglycemic. Animals were divided into four equal groups (7 per group). Animals in all groups were treated for 14 days. Blood samples were collected from the heart of the animals. Results: Continuous supplementation of ethanol extract in drinkable water of diabetic rats resulted to a significant decrease of fasting blood glucose, cholesterol and increase in high density lipoprotein levels after 14 days (P<0.05), but the levels of triglycerides, LDL-cholestrol, activities of alanine aminotransferase and aspartate aminotransferase did not changed significantly in treatment group compared to control group(P>0.05). Conclusion: This paper discussed the antidiabetic effect of an alcoholic extract of Ziziphus Jujuba on streptozocin-induced diabetes in rats. Researchers showed that Streptozocin injection led to diabetes mellitus, which may be due to destruction of β cells of the islets of Langerhans. [ABSTRACT FROM AUTHOR]
- Published
- 2014
36. Costs of Treatment after Renal Transplantation: Is it Worth to Pay More?
- Author
-
Salamzadeh, Jamshid, Foroutan, Naghmeh, Jamshidi, Hamid Reza, Rasekh, Hamid Reza, Ghatari, Ali Rajabzadeh, Foroutan, Arash, and Nafar, Mohsen
- Subjects
TRANSPLANTATION of organs, tissues, etc. ,DATABASES ,PHARMACY ,THERAPEUTICS ,TEACHER expenditures - Abstract
The primary aim of the study was to estimate costs of treatment for the first year after renal transplantation from the perspective of health insurance organizations in Iran. An Excel-based and a Monte Carlo model were developed to determine the treatment costs of current clinical practice in renal transplantation therapy (RTT). Inputs were derived from Ministry of Health and insurance organizations database, hospital and pharmacy records, clinical trials and local and international literature. According to the model, there were almost 17,000 patients receiving RTT in Iran, out of which about 2,200 patients underwent the operation within the study year (2011 - 2012; n = 2,200). The estimated first year total treatment cost after renal transplantation was almost $14,000,000. These costs corresponded to annual total cost per patient of almost $6500 for the payers. Renal transplantation therapy is almost fully reimbursed by government in Iran. However, regarding new expensive medicines, cost of medical expenditure is rapidly growing and becoming quite unaffordable for the government; therefore, out-of-pocket (OOP) payments are dramatically increasing over time. In order to improve reimbursement policy making under pressure of current budget constraints, the present study is providing decision makers with practical tools make it possible for them to easily compare budgetary impact of the current therapy strategy with the future financial consequences of purchasing newly proposed medicines. In other words having estimation of the current budget spending on RTT would help policy makers in making efficient resource allocation and decrease quite high OOP expenditures. [ABSTRACT FROM AUTHOR]
- Published
- 2014
37. National and subnational patterns of cause of death in Iran 1990-2015: Applied methods
- Author
-
Sheidaei, Ali, kimiya gohari, Kasaeian, Amir, Rezaei, Nazila, Mansouri, Anita, Khosravi, Ardeshir, Parsaeian, Mahboubeh, Mohammadi, Younes, Mehdipour, Parinaz, Rahimzadeh, Shadi, Sharifi, Farshad, Varmaghani, Mehdi, Chegini, Maryam, Naderimagham, Shohreh, Jamshidi, Hamid Reza, and Farzadfar, Farshad
38. National and Subnational Patterns of Cause of Death in Iran 1990-2015: Applied Methods.
- Author
-
Sheidaei, Ali, Gohari, Kimiya, Kasaeian, Amir, Mansouri, Anita, Khosravi, Ardeshir, Parsaeian, Mahboubeh, Mohammadi, Younes, Mehdipour, Parinaz, Rahimzadeh, Shadi, Shanfi, Farshad, Varmagham, Mehdi, Chegini, Maryam, Naderimagham, Shohreh, Jamshidi, Hamid Reza, and Farzadfar, Farshad
- Subjects
- *
CAUSES of death , *MAPS , *MORTALITY , *NOSOLOGY , *STATISTICAL models - Abstract
Background: Causes of death statistics provide crucial health intelligence in national and international communities. An efficient death registration system provides reliable information for health policy system. In many developing countries, death registration systems face a degree of misclassification and incompleteness. There are many impediments to putting an estimate of cause-specific death rates. Addressing those challenges could prevent misleading results. Methods: Our data was collected by Ministry of Health and Medical Education, Tehran and Isfahan cemeteries from 1995 to 2010. After converting ICD codes of Iran's death registration into GBD codes, 170 underlying causes of deaths were recognized in the available data. A wide range of methods were applied for preparing the data. We used several statistical models to estimate mortality rates in age-sex-province groups for all causes of deaths. The considerable number of combinations for age, sex, cause of death, year, and province variables made further complicated model selection and evaluation of the results. Results: Totally, 58.91 % of deaths were related to males. The majority of cases of death were classified as NCDs (77.83%) and injuries (14.80%). We extrapolated 71.76% and 14.71% of causes of death by mixed effect model, spline model with parameter 0.9 and 0.6, respectively. Conclusion: A comprehensive and unique registration system is able to solve many DRS issues. It is necessary to assess the quality and validity of cause of death data. Scientific methods like analyzing mortality level and cause-of-death data are used to provide an overview for better decisions. [ABSTRACT FROM AUTHOR]
- Published
- 2017
39. Burden of Cancers in Iran from 1990 to 2010: Findings from the Global Burden of Disease Study 2010.
- Author
-
Modirian, Mitra, Rahimzadeh, Shadi, Cheraghi, Zahra, Moghaddam, Sahar Saeedi, Rezaei, Nazila, Tolide-ie, Hamid Reza, Kasaeian, Amir, Jamshidi, Hamid Reza, Ghobadi, Roya, and Kompani, Farzad
- Subjects
- *
LIFE expectancy , *MORTALITY , *PEOPLE with disabilities , *TIME , *TUMORS , *DESCRIPTIVE statistics , *DISEASE complications ,TUMOR prevention - Abstract
Background: Cancer is one of the most common non-communicable diseases in both sexes and a major cause of disability and death around the world, as well as in Iran. The aim of the present manuscript is to report the results of the Global Burden of Disease study 2010 (the GBD 2010) to compare them with other similar findings. The paper also discusses the current deficiencies in the GBD study. Our aim was to describe and criticize the attributed burden of cancers according to the GBD results by sex and age. Methods: The GBD 2010 has profited from 100 collaborators worldwide and provides a vast network of data on health outcomes, vital registries, and population surveys. The GBD has used various scientific-approved methods to estimate important health statuses like death rates, life expectancy, and healthy adjusted life expectancy, disability-adjusted life years, years of living lost due to premature death and years of life with disabilities. In the present study, we extracted and graphed the GBD results for Iran in order to present a better scheme for readers. Results: The mortality rate of cancers in Iranians has increased by about 8.5%, while the disability-adjusted life year rates have declined by about 9%, and years lost due to premature death have also decreased by about 10% from 1990 to 2010 compared to an 85% increase in years of life with disabilities in the same time period. Conclusion: The burden of all non-communicable diseases (NCDs) including cancers shows a decrease during the past two decades. However, these diseases still remain a global health challenge. Prevention should be considered as an important priority and responsibility. The health authorities also need to determine the burden of cancers at national and sub-national levels for implementation of effective preventive strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
40. Burden of Drug and Alcohol Use Disorders in Iran: findings from the Global Burden of Disease Study 2010.
- Author
-
Moazen, Babak, Shokoohi, Mostafa, Noori, Atefeh, Rahimzadeh, Shadi, Moghaddam, Sahar Saeedi, Rezaei, Farimah, Lotfizadeh, Masoud, Kazemi, Mohammad Reza, Jamshidi, Hamid Reza, Pazhuheian, Forough, Rabbani, Setareh, and Naderimagham, Shohreh
- Abstract
Background: Due to its specific socio-cultural and geographical situation, Iran has a major public health problem in terms of drug and alcohol use. The aim of this study is to report and critique the burden of drug and alcohol use disorders in Iran, and to compare these measurements with similar findings. Methods: This study used data for Iran for the years 1990, 2005, and 2010 derived from the Global Burden of Disease study conducted by the Institute for Health Metrics and Evaluation (IHME) in 2010. The burden of drug and alcohol use disorders was evaluated in terms of disability adjusted life years (DALYs), years of life lost to premature mortality (YLLs), and years lived with disability (YLDs). Results: All rates were reported per 100,000 individuals. Death rates attributed to drug and alcohol use disorders were 7.7 and 0.16 for men, and 0.62 and 0.02 for women, respectively. YLL rates regarding drug use disorders were 351.8 and 24.8 for men and women, while these figures were 5.8 and 1.0 for alcohol use disorders for men and women, respectively. YLD rates of drug use disorders were 452.6 for men and 202.1 for women, and 105.8 for men and 23.7 for women for alcohol use disorders. DALY rates attributed to drug use disorders were 804.5 for men and 227 for women, while these rates were 111.7 for men and 24.7 for women, related to alcohol use disorders. Conclusions: Similar to the cases in many other countries, the burden of both drug and alcohol use disorders is higher for men than women in Iran. Although prevention policies and programs for drug and alcohol use are required for both genders, the need for drug and alcohol use intervention seems more urgent for men in Iran. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
41. The Most Prevalent Causes of Deaths, DALYs, and Geriatric Syndromes in Iranian Elderly People Between 1990 and 2010: findings from the Global Burden of Disease study 2010.
- Author
-
Shabestari, Alireza Namazi, Moghaddam, Sahar Saeedi, Sharifi, Farshad, Fadayevatan, Reza, Nabavizadeh, Fatemeh, Delavari, Alireza, Jamshidi, Hamid Reza, and Naderimagham, Shohreh
- Abstract
Background: The substantial increase in life expectancy during recent decades has left all countries with a high number of elderly people that have particular health needs. Health policy-makers must be aware of the most prevalent causes of deaths and DALYs in this age group, as well as geriatric syndromes, in order to provide appropriate care and allocate resources in an equitable manner. Methods: The Global Burden of Disease study 2010 (the GBD study 2010), conducted by the Institute for Health Metrics and Evaluation team, estimated the worldwide burden of diseases from 1990 to 2010. Its estimations were conducted on the basis of the proportion of deaths, the duration of symptoms and disability weights for sequelae, years lived with disability (YLDs), years of life lost (YLLs), and disability adjusted life years (DALYs) attributable to different diseases. In the present study, we extracted the data regarding the top five most prevalent causes of deaths, DALYs, and geriatric syndromes in the elderly based on the aforementioned the GBD study 2010, discussed the results using some tables and figures, reviewed the results, described the limitations of the GBD study 2010, and finally provided some recommendations as potential solutions. Results: According to the GBD study 2010, the total number of deaths in Iran in 1990 was 321,627, of which 116,100 were in elderly people (those aged 60 years and above), meaning that 36.10% of all deaths occurred in the elderly. Among all diseases in this year, the first to third ranked causes of death were ischemic heart disease (IHD; 29.44%), neoplasms (13.52%), and stroke (7.24%). In comparison, the total number of deaths in Iran increased to 351,814 in 2010, with 213,116 of these occurring in the elderly (60.58% of deaths), but the most prevalent causes of death remained the same as in 1990. The highest 1990 DALYs rates were the result of IHD (21.56%), neoplasms (10.70%), and stroke (4.85%). IHD (22.77%), neoplasms (9.48%), and low back pain (LBP; 5.72%) were the most prevalent causes of DALYs in older Iranian adults in 2010. The fourth and fifth ranked causes of deaths and DALYs in both 1990 and 2010, both in Iran and globally, were different diseases and geriatric syndromes in the elderly Iranian population. Conclusion: The aged population of Iran is growing steadily, and there is a need for health policy-makers to create appropriate programs to meet the health needs of elderly people. Although the GBD study results are useful in providing burden estimations at regional and national levels, each individual country should estimate its burden of diseases, injuries, and risk factors at a sub-national level to obtain further details regarding the health status of its people. As no comprehensive study regarding elderly people in Iran has previously been conducted, our study will be a major source for identifying the important causes of deaths, DALYs, and geriatric syndromes among this population. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
42. Tobacco Smoking Status and the Contribution to Burden of Diseases in Iran, 1990-2010: findings from the Global Burden of Disease Study 2010.
- Author
-
Ghasemian, Anoosheh, Rezaei, Nazila, Moghaddam, Sahar Saeedi, Mansouri, Anita, Parsaeian, Mahboubeh, Delavari, Alireza, Jamshidi, Hamid Reza, Sharifi, Farshad, and Naderimagham, Shohreh
- Abstract
Background: Tobacco smoking and exposure to second-hand smoke in the indoor environment are major public health risks worldwide. The aim of this paper is to report and critique a global assessment of smoking prevalence, smoking-attributable deaths, and disability adjusted life years (DALYs) extracted from the Global Burden of Disease study 2010, by sex and age in Iran from 1990 to 2010. Methods: The Global Burden of Disease Study 2010 estimated the distributions of exposure and relative risks per unit of exposure by systematically reviewing and analyzing published and unpublished data. These assessments were used, together with estimates of death and DALYs due to specific risk factors, to calculate the attributed burden for each risk factor exposure compared with the theoretical-minimum-risk exposure. Uncertainties in the distribution of exposure, relative risks, and relevant outcomes were incorporated into estimates of attributable mortality and burden. In this study, our aim was to reformulate the GBD 2010 data, produce new graphs, and explain the results for Iran in greater detail. Results: Between 1990 and 2010, the prevalence of tobacco smoking at all ages increased by 1 % in men and declined by 2% in women in Iran, but the overall prevalence in the general population was unchanged (12%). A reduction was observed in the age-standardized death and DALY rates (per 100,000 population) attributed to tobacco smoking, including second-hand smoke. The attributed DALY rate was greater for Iranian men than for Iranian women. The highest rates of DALYs because of tobacco smoking were found in smoker men and women aged 70+, but exposure to second-hand smoke had the most significant burden in children under 5 years old. In 1990, the three leading disease burdens attributed to tobacco smoking, including second-hand smoke, were ischemic heart disease; communicable, maternal, neonatal, and nutritional disorders; and chronic respiratory diseases. In 2010, three leading burden of diseases attributed to tobacco smoking belonged to ischemic heart disease, chronic respiratory disease, and cerebrovascular diseases, respectively. Conclusion: Despite a reduction in the rate of tobacco smoking, including second-hand smoke, since 1990, smoking exposure remained the fifth leading risk factor for death and DALYs in Iran in 2010. Overall, our data clearly show the need for new efforts in Iran to reduce the and disease burden attributed to tobacco smoking. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
43. Burden of Hepatitis C in Iran Between 1990 and 2010: findings from the Global Burden of Disease Study 2010.
- Author
-
Shalmani, Hamid Mohaghegh, Noori, Atefeh, Shokoohi, Mostafa, Khajavi, Alireza, Darvishi, Mohammad, Delavari, Alireza, Jamshidi, Hamid Reza, and Naderimagham, Shohreh
- Abstract
Background: Hepatitis C virus (HCV) is the foremost cause of deaths attributable to cirrhosis and hepatocellular carcinoma. The Global Burden of Disease study from 2010 (the GBD study 2010) quantifies and compares the degree of health loss as a result of diseases, injuries, and risk factors by age, sex, and geography overtime. This study aimed to present and critique the burden of hepatitis C and its trend in Iran between 1990 and 2010 by using the GBD study 2010. Methods: We used results of the GBD study 2010 between 1990 and 2010 for Iran to measure rates and trends of mortality, causes of deaths, years of life lost (YLLs), years lived with disability (YLDs), and disability adjusted life years (DALYs) due to hepatitis C. Hepatitis C was defined as the presence of hepatitis C virus in the serum. Data were presented in three categories: acute hepatitis C, cirrhosis secondary to hepatitis C, and liver cancer secondary to hepatitis C. Results: HCV infection (including the three categories of the study) led to 57.29, 59.92, and 66.45 DALYs (per 100,000 population) in 1990, 2000, and 2010, respectively. DALYs and death rates showed a slight decreasing trend for HCV cirrhosis; however, DALYs and death rates increased for acute hepatitis and liver cancer due to patients with HCV. The majority of deaths and DALYs were in individuals aged 70 years and above in all three categories of HCV. YLLs made the greatest contributions to DALYs. Conclusion: DALYs due to HCV infection are increasing in Iran according to the GBD study 2010; however, the estimations of DALYs using the GBD study 2010 are mostly from model-based data and there are significant uncertainties for extrapolated data. In this regard, a comprehensive study such as the National and Subnational Burden of Diseases (NASBOD) study would be needed to estimate and calculate precisely prevalence and burden of HCV-related diseases at national and subnational levels. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
44. National and Sub-national Burden of Breast Cancer in Iran; 1990-2013.
- Author
-
Naderimagham, Shohreh, Alipour, Sadaf, Djalalinia, Shirin, Kasaeian, Amir, Noori, Atefeh, Rahimzadeh, Shadi, Modirian, Mitra, Khosravi, Ardeshir, Etemad, Kourosh, Jamshidi, Hamid Reza, and Farzadfar, Farshad
- Abstract
BACKGROUND: Estimating the burden of diseases, injuries and major risk factors is necessary for adopting appropriate health policies in every country, and this paper aims to explain the study protocol of national and sub-national burden of breast cancer in Iran from 1990 to 2013. METHODS: We will perform a systematic review of the confirmed databases and literature to gather data on breast cancer epidemiology in Iran. The definitions, data sources, organizing the team, methods of data gathering and data generating will be explained in this paper. The methodology of estimating the trend of prevalence, years of life lost due to premature death (YLLs), years of life lost due to disability (YLDs) and disability-adjusted life years lost (DALYs) of breast cancer by age groups, provinces and probable inequalities will be explained. We will tackle possible data problems due to the lack of data points on provinces and years and also geographical misalignment by using two advanced statistical methods, namely Bayesian autoregressive multilevel and Spatio-temporal models. Trend estimation will be reported using these two models together with uncertainty intervals. CONCLUSION: This study provides a comprehensive assessment of breast cancer and its specific pattern in Iran. The results will help policy makers to know the trend of prevalence, the distribution, and the inequalities of breast cancer in Iran to allocate resources in a better way. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
45. National and Sub-national Prevalence, Trend, and Burden of End Stage Renal Diseases (ESRD) in Iran 1990-2013; The Study Protocol.
- Author
-
Hassannia, Tahereh, Farzadfar, Farshad, Noori, Atefeh, Moradi-Lakeh, Mazyar, Delavari, Farnaz, Jamshidi, Hamid Reza, Djalalinia, Shirin, and Naderimagham, Shohreh
- Abstract
BACKGROUND: End Stage Renal Diseases (ESRD) imposes a huge economic burden on the health system; however, there is a serious lack of data related to ESRD, especially at Sub-national level, in Iran. Calculating the burden of ESRD at National and Sub-national level provides an opportunity to apply cost-effective interventions for the purpose of prevention and treatment. The current study protocol aims to explain the general structure and methods that will be used in the burden of ESRD study in Iran from 1990 to 2013. METHODS: The prevalence, incidence, mortality and geographical and socioeconomic inequality trend of ESRD will be calculated through a comprehensive systematic review of published and unpublished data. Years of Life Lost due to premature mortality, and Years Lived with Disability and Disability-Adjusted Life Years (DALYs) will be quantified for ESRD by gender, age group, and province with their uncertainly intervals. “Spatio-Temporal” and “Bayesian multilevel autoregressive” will be applied to deal with data scarcity and misalignment problem which exist in the data sources. DISCUSSION: The findings of the burden of ESRD study will be useful to organize preventive, treatment also research priorities at national and sub-national levels in Iran. Better understanding of the magnitude of ESRD burden is essential to prevent the progression of chronic kidney diseases to the end stage phase which is considered as a devastating illness. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
46. National and Sub-national Burden of Chronic Diseases Attributable to Lifestyle Risk Factors in Iran 1990 - 2013; Study Protocol.
- Author
-
Ghasemian, Anoosheh, Ataie-Jafari, Asal, Khatibzadeh, Shahab, Mirarefin, Mojdeh, Jafari, Leili, Nejatinamini, Sara, Parsaeian, Mahboubeh, Peykari, Niloofar, Sobhani, Sahar, Jamshidbeygi, Esmat, Jamshidi, Hamid Reza, Ebrahimi, Mehdi, Etemad, Kourosh, Moradi-Lakeh, Maziar, Larijani, Bagher, and Farzadfar, Farshad
- Abstract
BACKGROUND: Non-communicable diseases, as the major public health problem, are caused by different risk factors. The main leading lifestyle risk factors for most diseases burden in Iran are unhealthy diet, physical inactivity, and smoking. The aim of this study is to provide data collection and methodology processes for estimating the trends of exposures to the selected lifestyle risk factors and their attributed burden at national and sub-national levels. METHODS: Systematic review will be performed through PubMed/MEDLINE, Scopus and ISI/Web of Science as well as Iranian databases such as IranMedex, Irandoc and Scientific Information Database (SID). In addition, hand searching of unpublished data sources will be used to identify relevant population-based studies. The searched studies will be included only if it is reasonably population-based and representative, and exposure data has been reported or could be plausibly obtained from the study. For risk factors with no surveys identified, other sources of potential data will be considered. The target population is healthy Iranian adult population living within Iran from 1990 to 2013. Other data sources include national censuses, national registration systems, and national and sub-national surveys. Spatio-temporal Bayesian hierarchical model and Bayesian multilevel autoregressive model will be used to overcome the problem of data gaps in provinces, and in some age or sex groups or in urban/rural areas. The problem of misaligned areal units will be also addressed in these models. CONCLUSION: National and sub-national assessment of major lifestyle risk factors such as unhealthy diet, physical inactivity, and smoking is necessary for priority setting and policy making in different regions of Iran. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
47. National and Sub-national Trend and Burden of Injuries in Iran, 1990 - 2013: A Study Protocol.
- Author
-
Jamshidbeygi, Esmat, Rastad, Hadith, Qorbani, Mostafa, Saadat, Soheil, Sepidarkish, Mehdi, Asayesh, Hamid, Sepanlou, Sadaf. G., Shokraneh, Farhad, Najafi, Fereshteh, Khoramdad, Malihe, Maghsodi, Ahmad, Farzadfar, Farahnaz, Jamshidi, Hamid Reza, Moradi-Lakeh, Maziar, and Farzadfar, Farshad
- Abstract
BACKGROUND: Worldwide, injuries are a major public health concern and make a considerable contribution to the disease burden. The present study is a component of the National and Subnational Burden of Diseases, Injuries, and Risk Factors from 1990 to 2013 (NASBOD) study in Iran, which was designed to investigate the burden of most important injuries (road traffic injuries, falls, burns, poisonings and drownings) at the national and sub-national levels in Iran. In this paper we explain definitions, organization, injuries selection process, data sources, data gathering methods, and data analyses of the national and sub-national burden of injuries study in Iran. METHODS: The burden of most important injuries in current metric of DALYs at the national and sub-national levels in Iran over 1990-2013 will be estimated through comprehensive reviews of either published or national data sources. Statistical modeling will be used to impute the missing data on the burden of selected important injuries for each district-year. CONCLUSION: The results of present study can help health policy makers to plan more comprehensive and cost-effective strategies at national and sub-national level for prevention and control of burden caused by injuries. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
48. NASBOD 2013: Design, Definitions, and Metrics.
- Author
-
Farzadfar, Farshad, Delavari, Alireza, Malekzadeh, Reza, Mesdaghinia, Alireza, Jamshidi, Hamid Reza, Sayyari, Aliakbar, and Larijani, Bagher
- Abstract
BACKGROUND: Iran has witnessed a substantial demographic and health transition, especially during the past 2 decades, which necessitates updated evidence-based policies at national and indeed at subnational scale. The National and Subnational Burden of Diseases, Injuries, and Risk Factors (NASBOD) Study aims to provide the required evidence based on updated data sources available in Iran and novel methods partly adopted from Global Burden of Disease 2010. OBJECTIVE: This paper aims at explaining the motives behind the study, the design, the definitions, the metrics, and the challenges due to limitations in data availability.METHODS: All available published and unpublished data sources will be used for estimating the burden of 291 diseases and 67 risk factors from 1990 to 2013 at national and subnational scale. Published data will be extracted through systematic review. Existing population-based data sources include: registries (death and cancer), Demographic and Health Surveys, National Health Surveys, and other population-based surveys such as Non_Communicable Diseases Surveillance Surveys. Covariates will be extracted from censuses and household expenditure surveys. Hospital records and outpatient data will be actively collected as two distinct projects. Due to lack of data points by year and province, statistical methods will be used to impute the lacking data points based on determined covariates. Two main models will be used for data imputation: Bayesian Autoregressive Multi-level models and Spatio-Temporal regression models. The results from all available models will be used in an Ensemble Model to obtain the final estimates. Five metrics will be used for estimating the burden: prevalence, death, Years of Life Lost due to premature death (YLL), Years of Life Lost due to Disability (YLD), and Disability-Adjusted Life Years Lost (DALY). Burden attributable to risk factors will be estimated through comparative risk assessment based on Population Attributable Fraction (PAF). Uncertainty Intervals (UIs) will be calculated and reported for all aforementioned metrics. RESULTS: We will estimate trends in terms of prevalence, deaths, YLLs, YLDs, and DALYs for Diseases, Injuries, and Risk Factors province from 1990 to 2013. CONCLUSION: Results of the present study will have implications for policy making as they address health gaps in Iranian population and their inequality between provinces. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
49. Using drug sales data to evaluate the epidemiology of cardiometabolic risk factors and their inequality: an ecological study on atorvastatin and total cholesterol in Iran.
- Author
-
Ahmadvand A, Farzadfar F, Jamshidi HR, Mohammadi N, and Holakouie-Naieni K
- Abstract
Background: Statins have been effective medications in lowering serum total cholesterol (TC) concentrations across populations over time. The aim of this study was to estimate national and provincial trends in atorvastatin sales in Iran, to systematically quantify its relationship with socioeconomic indicators, and changes in TC level., Methods: In this retrospective ecological study, conducted in Iran, we examined trends in atorvastatin sales, the wealth index (WI) as a validly-available socio-economic indicator, and TC level between 2004 and 2011. The main outcome variable was mean atorvastatin sold in defined daily dose per 100,000 people per day (DPD). We analyzed the relationship between WI and DPD and between DPD and mean TC across time and space., Results: At national level, both mean WI and mean DPD showed increasing trend over time, while we observed decreasing trend for TC. Mean WI and DPD in 2011 was nearly 5 and 50 time that of their respective figures in 2004, while the mean TC decreased for nearly 10%. Increases in both WI and DPD had happened in every province, but with different patterns. The maximum and minimum changes in DPD versus WI were seen in Gilan and North Khorasan respectively., Conclusion: A striking increase occurred in the sales for atorvastatin in Iran from 2004-2012 in most provinces examined. The wealthier a province became, the more sales were seen for atorvastatin. TC optimistically decreased from 2005 to 2011 and its decrease was positively correlated with increasing sales for atorvastatin.
- Published
- 2015
50. The Most Prevalent Causes of Deaths, DALYs, and Geriatric Syndromes in Iranian Elderly People Between 1990 and 2010: findings from the Global Burden of Disease study 2010.
- Author
-
Namazi Shabestari A, Saeedi Moghaddam S, Sharifi F, Fadayevatan R, Nabavizadeh F, Delavari A, Jamshidi HR, and Naderimagham S
- Subjects
- Accidental Falls mortality, Aged, Aged, 80 and over, Dementia mortality, Diabetes Mellitus mortality, Female, Health Surveys, Humans, Iran epidemiology, Low Back Pain epidemiology, Male, Middle Aged, Myocardial Ischemia mortality, Neoplasms mortality, Pulmonary Disease, Chronic Obstructive mortality, Stroke mortality, Cause of Death, Disabled Persons statistics & numerical data
- Abstract
Background: The substantial increase in life expectancy during recent decades has left all countries with a high number of elderly people that have particular health needs. Health policy-makers must be aware of the most prevalent causes of deaths and DALYs in this age group, as well as geriatric syndromes, in order to provide appropriate care and allocate resources in an equitable manner., Methods: The Global Burden of Disease study 2010 (GBD 2010), conducted by the institute for Health Metrics and Evaluation team, estimated the worldwide burden of diseases from 1990 to 2010. Its estimations were conducted on the basis of the proportion of deaths, the duration of symptoms and disability weights for sequelae, years lived with disability (YLDs), years of life lost (YLLs), and disability adjusted life years (DALYs) attributable to different diseases. In the present study, we extracted the data regarding the top five most prevalent causes of deaths, DALYs, and geriatric syndromes in the elderly based on the aforementioned GBD 2010, discussed the results using some tables and figures, reviewed the results, described the limitations of GBD 2010, and finally provided some recommendations as potential solutions., Results: According to GBD 2010, the total number of deaths in Iran in 1990 was 321,627, of which 116,100 were in elderly people (those aged 60 years and above), meaning that 36.10% of all deaths occurred in the elderly. Among all diseases in this year, the first to third ranked causes of death were ischemic heart disease (IHD; 29.44%), neoplasms (13.52%), and stroke (7.24%). In comparison, the total number of deaths in Iran increased to 351,814 in 2010, with 213,116 of these occurring in the elderly (60.58% of deaths), but the most prevalent causes of death remained the same as in 1990. The highest 1990 DALYs rates were the result of IHD (21.56%), neoplasms (10.70%), and stroke (4.85%). IHD (22.77%), neoplasms (9.48%), and low back pain (LBP; 5.72%) were the most prevalent causes of DALYs in older Iranian adults in 2010. The fourth and fifth ranked causes of deaths and DALYs in both 1990 and 2010, both in Iran and globally, were different diseases and geriatric syndromes in the elderly Iranian population., Conclusion: The aged population of Iran is growing steadily, and there is a need for health policy-makers to create appropriate programs to meet the health needs of elderly people. Although GBD 2010 results are useful in providing burden estimations at regional and national levels, each individual country should estimate its burden of diseases, injuries, and risk factors at a sub-national level to obtain further details regarding the health status of its people. As no comprehensive study regarding elderly people in Iran has previously been conducted, our study will be a major source for identifying the important causes of deaths, DALYs, and geriatric syndromes among this population.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.